Vitalibis Inc (VCBD)
0.00
USD |
OTCM |
May 03, 16:00
Vitalibis Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.754 |
| December 31, 2019 | -0.972 |
| September 30, 2019 | -0.7931 |
| Date | Value |
|---|---|
| June 30, 2019 | -1.204 |
| March 31, 2019 | 1.108 |
| December 31, 2018 | 0.0292 |
| September 30, 2018 | 0.0295 |
| June 30, 2018 | 0.0095 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.204
Minimum
Jun 2019
--
Maximum
Jun 2020
-0.6206
Average
-0.7735
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Liabilities (Quarterly) | 0.1049M |
| Shareholders Equity (Quarterly) | -0.1049M |